Abstract
Stem cells – based therapy is one of the most promising therapeutic approaches for amyotrophic lateral sclerosis (ALS), which is a fatal neurodegenerative disease without cure. This paper reviews the most intriguing pre-clinical and clinical studies and reports the current status of knowledge regarding ALS pathogenesis, confronting it with stem cell applications and their effects. Here we summarize various therapeutic approaches with respect to different sources of stem cells and diverse administration routes. Observed slow down of the disease progression and acceptable side effects emerge as the solid basis for optimism regarding the potential of the stem cell therapy for ALS.
Keywords: cell transplantation, administration route, regenerative medicine, amyotrophic lateral sclerosis, stem cells, therapy, neural stem cells, mesenchymal stem cells, growth factors, rats, mice, clinical trial, delivery, dose, iPS, cell replacement
Current Signal Transduction Therapy
Title: The Therapeutic Potential of Stem Cells in Amyotrophic Lateral Sclerosis
Volume: 6 Issue: 3
Author(s): Dinko Mitrecic, Charles Nicaise, Srecko Gajovic and Roland Pochet
Affiliation:
Keywords: cell transplantation, administration route, regenerative medicine, amyotrophic lateral sclerosis, stem cells, therapy, neural stem cells, mesenchymal stem cells, growth factors, rats, mice, clinical trial, delivery, dose, iPS, cell replacement
Abstract: Stem cells – based therapy is one of the most promising therapeutic approaches for amyotrophic lateral sclerosis (ALS), which is a fatal neurodegenerative disease without cure. This paper reviews the most intriguing pre-clinical and clinical studies and reports the current status of knowledge regarding ALS pathogenesis, confronting it with stem cell applications and their effects. Here we summarize various therapeutic approaches with respect to different sources of stem cells and diverse administration routes. Observed slow down of the disease progression and acceptable side effects emerge as the solid basis for optimism regarding the potential of the stem cell therapy for ALS.
Export Options
About this article
Cite this article as:
Mitrecic Dinko, Nicaise Charles, Gajovic Srecko and Pochet Roland, The Therapeutic Potential of Stem Cells in Amyotrophic Lateral Sclerosis, Current Signal Transduction Therapy 2011; 6 (3) . https://dx.doi.org/10.2174/157436211797483985
DOI https://dx.doi.org/10.2174/157436211797483985 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Sirtuins as Possible Targets in Neurodegenerative Diseases
Current Drug Targets Novel Approaches for Potential Therapy of Cystic Fibrosis
Current Drug Targets The Role of Calcium Stores in Apoptosis and Autophagy
Current Molecular Medicine Melatonin Synthetic Analogs as Nitric Oxide Synthase Inhibitors
Mini-Reviews in Medicinal Chemistry Neuroimmune Crosstalk in CNS Disorders: The Histamine Connection
Current Pharmaceutical Design Metal Protein Attenuating Compounds (MPACs): An Emerging Approach for the Treatment of Neurodegenerative Disorders
Current Bioactive Compounds A Quantitative Proteomic Analysis to Reveal Effects of N-acetylcysteine on H<sub>2</sub>O<sub>2</sub>-induced Cytotoxicity
Current Proteomics Glutamate Receptors in Human Caudate Nucleus in Normal Aging and Alzheimer’s Disease
Current Alzheimer Research RhoGEFs in Cell Motility: Novel Links Between Rgnef and Focal Adhesion Kinase
Current Molecular Medicine Single-dose Pharmacokinetics and Tolerability of Oral Delta-9- Tetrahydrocannabinol in Patients with Amyotrophic Lateral Sclerosis
Drug Metabolism Letters Targeting Neurotrophin Receptors in the Central Nervous System
CNS & Neurological Disorders - Drug Targets The Ubiquitin Proteasome System as a Potential Target for the Treatment of Neurodegenerative Diseases
Current Pharmaceutical Design Microencapsulation: The Emerging Role of Microfluidics
Micro and Nanosystems Antisynthetase Syndrome: A Review of Etiopathogenesis, Diagnosis and Management
Current Medicinal Chemistry Nanoneuromedicines for Neurodegenerative Diseases
Nanoscience & Nanotechnology-Asia Current Antioxidant Molecular Therapies for Oxidative Stress-Related Ailments
Current Gene Therapy Environmental Enrichment as a Positive Behavioral Intervention Across the Lifespan
Current Neuropharmacology Targeting Neurotrophic/Growth Factor Expression and Signaling for Antidepressant Drug Development
CNS & Neurological Disorders - Drug Targets Neurotrophic Factor Treatment After Spinal Root Avulsion Injury
Central Nervous System Agents in Medicinal Chemistry Functionalized magnetic nanoparticles for biomedical applications
Current Pharmaceutical Design